Page last updated: 2024-09-03

schizandrin c and Benign Neoplasms

schizandrin c has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gui, S; Guo, J; He, G; Li, Z; Lv, X; Ma, X; Tao, Q; Tao, Y; Wei, W; Zhang, M1
Chang, JB; Li, YF; Wang, Q1

Reviews

1 review(s) available for schizandrin c and Benign Neoplasms

ArticleYear
Synthesis and biological activity of Wuweizisu C and analogs.
    Current topics in medicinal chemistry, 2009, Volume: 9, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Biological Products; Cyclooctanes; Hepatitis B; Humans; Lignans; Neoplasms; Polycyclic Compounds

2009

Other Studies

1 other study(ies) available for schizandrin c and Benign Neoplasms

ArticleYear
SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous Cap as potential immunomodulatory agents for cancer therapy.
    Bioorganic chemistry, 2022, Volume: 127

    Topics: Animals; Antineoplastic Agents; Cyclooctanes; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Immunomodulating Agents; Lignans; Neoplasms; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2022